• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Maraviroc for HIV: Responses at 48 Weeks

0
  • by alexperjescuadmin
  • in General Medicine
  • — 20 Sep, 2007
Maraviroc for HIV: Responses at 48 Weeks
AudioMedica News
Maraviroc for HIV: Responses at 48 Weeks
Maraviroc for HIV: Responses at 48 Weeks
00:00 /
RSS Feed
Share
Link
Embed
Jacob Lalezari
Jacob Lalezari

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JACOB LALEZARI, Quest Clinical Research, San Francisco
Maraviroc could be a useful new drug for the treatment of some HIV infections, according to Jacob Lalezari of Quest Clinical Research in San Francisco. He presented 48 week results from the MOTIVATE 1 study and Derek Thorne spoke to him at ICAAC in Chicago.

[audio:https://www.audiomedica.com/podcasting/general_medicine/070918JacobLalezari.mp3]
Share

Tags: antimicrobialhivicaacinfectionjacob lalezarimaraviroc

You may also like...

  • Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer 21 Mar, 2008
  • Audio Journal of Hematologic Malignancy, Volume 2 Number 1 Audio Journal of Hematologic Malignancy, Volume 2 Number 1 8 Jan, 2006
  • Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses 19 Sep, 2007
  • BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns 21 Sep, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Starting Antiretroviral Therapy Can Trigger Leprosy
  • Next story Monoclonal Antibody to Help Treat HIV?
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Brachytherapy “Excellent” After Breast…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Pembrolizuab Monotherapy Extended Survival in…
  • Home
  • General Medicine
  • Maraviroc for HIV: Responses at 48 Weeks

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.